RxDoctor Payments Data

Hee So, MD

Psychiatry · Jersey City, NJNPI 1215080270

Payments from drug & device makers

$2,364in general payments, 2019–2025

Across 162 payments — averaging $14.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$397
  • Takeda Pharmaceuticals U.S.A., Inc.$279
  • Jazz Pharmaceuticals Inc.$265
  • Axsome Therapeutics, Inc.$211
  • Otsuka America Pharmaceutical, Inc.$197
  • Teva Pharmaceuticals USA, Inc.$124
  • plus $891 from 17 others

What the payments were for

  • Food & beverage$2,31098%
  • Education$552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,364 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$33,277
Medicare patients
47
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuboxoneBuprenorphine Hcl/Naloxone Hcl38$19,158
TrintellixVortioxetine Hydrobromide17$7,995
Lisdexamfetamine Dimesylate22$6,685
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl69$5,668
StratteraAtomoxetine Hcl11$4,869
Alprazolam253$1,600
Oxcarbazepine25$1,502
Lamotrigine181$1,478
Atomoxetine Hcl12$1,224
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine37$1,209
Aripiprazole43$1,140
Trazodone Hcl96$1,131
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine31$1,067
Quetiapine Fumarate ErQuetiapine Fumarate23$862
Divalproex Sodium ErDivalproex Sodium14$712

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Suboxone$42$19,15838 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$279$7,99517 claims
Almatica Pharma LLCSertraline Hcl$30$26138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Jersey City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →